These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 519177)

  • 1. Treatment of advanced prostatic carcinoma.
    Br Med J; 1979 Sep; 2(6193):752-3. PubMed ID: 519177
    [No Abstract]   [Full Text] [Related]  

  • 2. The questionable use of hormone therapy in advanced carcinoma of the prostate.
    Murphy GP; Slack NH
    Urol Clin North Am; 1980 Oct; 7(3):631-8. PubMed ID: 6161459
    [No Abstract]   [Full Text] [Related]  

  • 3. The EORTC Phase III trials in prostatic cancer.
    Robinson MR; Smith PH; Macaluso MP; Sylvester R; de Voogt H
    Prog Clin Biol Res; 1985; 185A():243-9. PubMed ID: 3898132
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination of hormonal and cytostatic treatment for advanced carcinoma of the prostate.
    Servadio C
    Prog Clin Biol Res; 1985; 185A():407-26. PubMed ID: 4034582
    [No Abstract]   [Full Text] [Related]  

  • 5. A randomized double blind crossover trial of diethylstilbestrol (DES) and estramustine phosphate (Emcyt) for stage D prostatic carcinoma.
    Benson RC; Gill GM; Cummings KB
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):43-5. PubMed ID: 6364366
    [No Abstract]   [Full Text] [Related]  

  • 6. Is there a best endocrine management of prostatic carcinoma?
    Robinson MR
    Prog Clin Biol Res; 1988; 269():147-58. PubMed ID: 2969114
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical management of advanced prostatic carcinoma with stilphostrol.
    Lee JW
    Conn Med; 1974 May; 38(5):221-5. PubMed ID: 4831098
    [No Abstract]   [Full Text] [Related]  

  • 8. Lessons from phase III-trials on the hormonal treatment of prostatic cancer. I: Results of EORTC-trials 30761 and 30762.
    de Voogt HJ; Pavone-Macaluso M; Smith PH; de Pauw M; Suciu S
    Prog Clin Biol Res; 1988; 260():111-7. PubMed ID: 2966403
    [No Abstract]   [Full Text] [Related]  

  • 9. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate.
    Nickel CJ; Morales A
    Can J Surg; 1983 Sep; 26(5):434-8. PubMed ID: 6351988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estramustine phosphate vs diethylstilbestrol in the treatment of stage D prostate cancer.
    Benson RC; Cummings K
    Prog Clin Biol Res; 1989; 303():177-86. PubMed ID: 2674984
    [No Abstract]   [Full Text] [Related]  

  • 11. French multicenter study on the use of estramustine phosphate versus diethylstilbestrol.
    Hauchecorne J
    Prog Clin Biol Res; 1987; 243B():229-34. PubMed ID: 3309983
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of treatment with diethylstilbestrol-polyestradiol phosphate or estramustine phosphate (estracyt) on natural killer cell activity in patients with prostatic cancer.
    Kalland T; Haukaas S
    Invest Urol; 1981 May; 18(8):437-9. PubMed ID: 7228576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remarkable effect of endocrine therapy on brain metastasis from prostatic carcinoma.
    Senoh H; Ichikawa Y; Matsuda M; Iwatsubo H; Kumahara Y; Sagawa S
    Urology; 1989 Mar; 33(3):243-6. PubMed ID: 2919489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Problems of treatment of prostatic cancer].
    Rutkowski A
    Wiad Lek; 1980 Sep; 33(18):1461-6. PubMed ID: 6781145
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of metastatic prostatic cancer.
    Paulson DF
    Urology; 1985 Feb; 25(2 Suppl):49-52. PubMed ID: 3918376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma changes caused by estrogens in the vascular risk of prostatic carcinoma over a 3-year period].
    Daponte DP; Stevens I; Robinson MR
    Actas Urol Esp; 1986; 10(6):437-40. PubMed ID: 3825644
    [No Abstract]   [Full Text] [Related]  

  • 17. Estramustine for prostate cancer.
    Med Lett Drugs Ther; 1982 Aug; 24(615):74. PubMed ID: 7099111
    [No Abstract]   [Full Text] [Related]  

  • 18. Continuous versus intermittent oral therapy with estramustine phosphate (Estracyt).
    Vahlensieck W; Wegner G
    Scand J Urol Nephrol Suppl; 1980; 55():147-9. PubMed ID: 6938018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endocrine therapy of stage D2 prostatic carcinoma].
    Akimoto S; Akakura K; Fuse H; Shimazaki J; Yatani R
    Nihon Hinyokika Gakkai Zasshi; 1988 Jan; 79(1):1-10. PubMed ID: 2456417
    [No Abstract]   [Full Text] [Related]  

  • 20. Activity of phagocytic granulocytes in patients with prostatic cancer.
    Hofmann R; Lehmer A; Braun J; Bauer S
    Urol Res; 1986; 14(6):327-30. PubMed ID: 3811082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.